Knockdown of c-Fos suppresses the growth of human colon carcinoma cells in athymic mice

International Journal of Cancer

Volumn 130, Issue 1, 2012, Pages 213-222

  Pandey, Manoj K ^a   Liu, Guangming ^a   Cooper, Timothy K ^a   Mulder, Kathleen M ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

AP 1; c Fos; colon carcinoma; TGF ; xenograft

Indexed keywords

PROTEIN C FOS; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INHIBITION; COLON CARCINOMA; CONTROLLED STUDY; DRUG EFFICACY; GENE ACTIVITY; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REPORTER GENE; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; COLONIC NEOPLASMS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; IMMUNOENZYME TECHNIQUES; LUCIFERASES; MICE; MICE, INBRED BALB C; MICE, NUDE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-FOS; REAL-TIME POLYMERASE CHAIN REACTION; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR AP-1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 80255137098     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25997     Document Type: Article

References (50)

1. Massague J,. TGFbeta in Cancer. Cell 2008; 134: 215-30.
2. Hartsough MT, Mulder KM,. Transforming growth factor-beta signaling in epithelial cells. Pharmacol Ther 1997; 75: 21-41. (Pubitemid 27444685)
3. Ko TC, Sheng HM, Reisman D, Thompson EA, Beauchamp RD,. Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene 1995; 10: 177-84.
4. Yue J, Mulder KM,. Transforming growth factor-beta signal transduction in epithelial cells. Pharmacol Ther 2001; 91: 1-34. (Pubitemid 33055772)
5. Derynck R, Akhurst RJ, Balmain A,. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001; 29: 117-29. (Pubitemid 32952643)
6. Gold LI,. The role for transforming growth factor-beta (TGF-beta) in human cancer. Crit Rev Oncog 1999; 10: 303-60. (Pubitemid 30058460)
7. Markowitz S, TGF-beta receptors and DNA repair genes, coupled targets in a pathway of human colon carcinogenesis. Biochim Biophys Acta 2000; 1470: M13-20. (Pubitemid 30070164)
8. Zhou GH, Sechrist GL, Brattain MG, Mulder KM,. Clonal heterogeneity of the sensitivity of human colon carcinoma cell lines to TGE beta isoforms. J Cell Physiol 1995; 165: 512-20. (Pubitemid 26004308)
9. Zhou GH, Sechrist GL, Periyasamy S, Brattain MG, Mulder KM,. Transforming growth factor beta isoform-specific differences in interactions with type I and II transforming growth factor beta receptors. Cancer Res 1995; 55: 2056-62.
10. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995; 268: 1336-8.
11. Buard A, Zipfel PA, Frey RS, Mulder KM,. Maintenance of growth factor signaling through Ras in human colon carcinoma cells containing K-ras mutations. Int J Cancer 1996; 67: 539-46. (Pubitemid 26274112)
12. Tuxhorn JA, McAlhany SJ, Yang F, Dang TD, Rowley DR,. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res 2002; 62: 6021-5. (Pubitemid 35244446)
13. Terabe M, Matsui S, Park JM, Mamura M, Noben-Trauth N, Donaldson DD, Chen W, Wahl SM, Ledbetter S, Pratt B, Letterio JJ, Paul WE, et al. Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J Exp Med 2003; 198: 1741-52. (Pubitemid 37494166)
14. Liu G, Ding W, Liu X, Mulder KM,. c-Fos is required for TGFbeta1 production and the associated paracrine migratory effects of human colon carcinoma cells. Mol Carcinog 2006; 45: 582-93. (Pubitemid 44205098)
15. Barnard JA, Warwick GJ, Gold LI,. Localization of transforming growth factor beta isoforms in the normal murine small intestine and colon. Gastroenterology 1993; 105: 67-73. (Pubitemid 23234021)
16. Kim SJ, Glick A, Sporn MB, Roberts AB,. Characterization of the promoter region of the human transforming growth factor-beta 1 gene. J Biol Chem 1989; 264: 402-8. (Pubitemid 19027618)
17. Kim SJ, Jeang KT, Glick AB, Sporn MB, Roberts AB,. Promoter sequences of the human transforming growth factor-beta 1 gene responsive to transforming growth factor-beta 1 autoinduction. J Biol Chem 1989; 264: 7041-5. (Pubitemid 19114823)
18. Yue J, Mulder KM,. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a smad-dependent pathway. J Biol Chem 2000; 275: 35656.
19. Kim SJ, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, Karin M, Roberts AB,. Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol 1990; 10: 1492-7.
20. Angel P, Karin M,. The role of Jun. Fos and the. AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072: 129-57. (Pubitemid 121007534)
21. Mulder KM,. Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 2000; 11: 23-35. (Pubitemid 30169723)
22. Jin Q, Ding W, Staub CM, Gao G, Tang Q, Mulder KM,. Requirement of km23 for TGFbeta-mediated growth inhibition and induction of fibronectin expression. Cell Signal 2005; 17: 1363-72. (Pubitemid 41206646)
23. Wu SP, Theodorescu D, Kerbel RS, Willson JK, Mulder KM, Humphrey LE, Brattain MG,. TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J Cell Biol 1992; 116: 187-96.
24. Shi SR, Key ME, Kalra KL,. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39: 741-8.
25. Chakravarti N, Lotan R, Diwan AH, Warneke CL, Johnson MM, Prieto VG,. Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis. Clin Cancer Res 2007; 13: 4817-24. (Pubitemid 47294789)
26. Brattain MG, Levine AE, Chakrabarty S, Yeoman LC, Willson JK, Long B,. Heterogeneity of human colon carcinoma. Cancer Metastasis Rev 1984; 3: 177-91.
27. Mulder KM, Brattain MG,. Growth factor expression and response in human colon carcinoma cellsed. Boca Raton: CRC Press, 1989.
28. Takakura M, Kyo S, Inoue M, Wright WE, Shay JW,. Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells. Mol Cell Biol 2005; 25: 8037-43. (Pubitemid 41262997)
29. Fearon ER, Vogelstein B,. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
30. Xu Y, Pasche B,. TGF-beta signaling alterations and susceptibility to colorectal cancer. Hum Mol Genet 2007; 16: R14-20. (Pubitemid 47241839)
31. Wang J, Han W, Zborowska E, Liang J, Wang X, Willson JK, Sun L, Brattain MG,. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells. J Biol Chem 1996; 271: 17366-71. (Pubitemid 26244298)
32. Akhurst RJ, Derynck R,. TGF-beta signaling in cancer-a double-edged sword. Trends Cell Biol 2001; 11: S44-51.
33. Avery A, Paraskeva C, Hall P, Flanders KC, Sporn M, Moorghen M,. TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. Br J Cancer 1993; 68: 137-9. (Pubitemid 23178566)
34. Oshima H, Oshima M, Kobayashi M, Tsutsumi M, Taketo MM,. Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice. Cancer Res 1997; 57: 1644-9. (Pubitemid 27199651)
35. Liu G, Chen N, Kaji A, Bode AM, Ryan CA, Dong Z,. Proteinase inhibitors I and II from potatoes block UVB-induced AP-1 activity by regulating the AP-1 protein compositional patterns in JB6 cells. Proc Natl Acad Sci USA 2001; 98: 5786-91. (Pubitemid 32435720)
36. Volm M, Drings P, Wodrich W,. Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas. J Cancer Res Clin Oncol 1993; 119: 507-10. (Pubitemid 23180039)
37. Saez E, Rutberg SE, Mueller E, Oppenheim H, Smoluk J, Yuspa SH, Spiegelman BM,. c-fos is required for malignant progression of skin tumors. Cell 1995; 82: 721-32.
38. Jin SP, Kim JH, Kim MA, Yang HK, Lee HE, Lee HS, Kim WH,. Prognostic significance of loss of c-fos protein in gastric carcinoma. Pathol Oncol Res 2007; 13: 284-9. (Pubitemid 351287308)
39. Lu C, Shen Q, DuPre E, Kim H, Hilsenbeck S, Brown PH,. cFos is critical for MCF-7 breast cancer cell growth. Oncogene 2005; 24: 6516-24. (Pubitemid 41486634)
40. Wang ZQ, Grigoriadis AE, Mohle-Steinlein U, Wagner EF,. A novel target cell for c-fos-induced oncogenesis: development of chondrogenic tumours in embryonic stem cell chimeras. EMBO J 1991; 10: 2437-50. (Pubitemid 21905717)
41. Grigoriadis AE, Schellander K, Wang ZQ, Wagner EF,. Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 1993; 122: 685-701. (Pubitemid 23226685)
42. Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT, Xia YJ, Ye ZY, Tao HQ,. MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 46: 2295-303.
43. Li S, Fu H, Wang Y, Tie Y, Xing R, Zhu J, Sun Z, Wei L, Zheng X,. MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. Hepatology 2009; 49: 1194-202.
44. Shaulian E, Karin M,. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002; 4: E131-6. (Pubitemid 34521026)
45. Sherwood DR, Butler JA, Kramer JM, Sternberg PW,. FOS-1 promotes basement-membrane removal during anchor-cell invasion in C. elegans. Cell 2005; 121: 951-62. (Pubitemid 40806425)
46. Milde-Langosch K,. The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer 2005; 41: 2449-61. (Pubitemid 41540622)
47. Hu E, Mueller E, Oliviero S, Papaioannou VE, Johnson R, Spiegelman BM,. Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J 1994; 13: 3094-103. (Pubitemid 24213461)
48. Chang YJ, Wu MS, Lin JT, Chen CC,. Helicobacter pylori-Induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation. J Immunol 2005; 175: 8242-52.
49. Gebhardt C, Breitenbach U, Tuckermann JP, Dittrich BT, Richter KH, Angel P,. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis. Oncogene 2002; 21: 4266-76. (Pubitemid 34753833)
50. Liu G, Ding W, Neiman J, Mulder KM,. Requirement of Smad3 and CREB-1 in mediating transforming growth factor-beta (TGF beta) induction of TGF beta 3 secretion. J Biol Chem 2006; 281: 29479-90. (Pubitemid 44536956)